BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26014047)

  • 1. CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma.
    Viaccoz A; Ducray F; Tholance Y; Barcelos GK; Thomas-Maisonneuve L; Ghesquières H; Meyronet D; Quadrio I; Cartalat-Carel S; Louis-Tisserand G; Jouanneau E; Guyotat J; Honnorat J; Perret-Liaudet A
    Neuro Oncol; 2015 Nov; 17(11):1497-503. PubMed ID: 26014047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylated markers accurately distinguish primary central nervous system lymphomas (PCNSL) from other CNS tumors.
    Downs BM; Ding W; Cope LM; Umbricht CB; Li W; He H; Ke X; Holdhoff M; Bettegowda C; Tao W; Sukumar S
    Clin Epigenetics; 2021 May; 13(1):104. PubMed ID: 33952317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid levels of neopterin are elevated in delirium after hip fracture.
    Hall RJ; Watne LO; Idland AV; Raeder J; Frihagen F; MacLullich AM; Staff AC; Wyller TB; Fekkes D
    J Neuroinflammation; 2016 Jun; 13(1):170. PubMed ID: 27357281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein biomarker identification in the CSF of patients with CNS lymphoma.
    Roy S; Josephson SA; Fridlyand J; Karch J; Kadoch C; Karrim J; Damon L; Treseler P; Kunwar S; Shuman MA; Jones T; Becker CH; Schulman H; Rubenstein JL
    J Clin Oncol; 2008 Jan; 26(1):96-105. PubMed ID: 18056677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter proof-of-concept study on deep learning-based intraoperative discrimination of primary central nervous system lymphoma.
    Zhang X; Zhao Z; Wang R; Chen H; Zheng X; Liu L; Lan L; Li P; Wu S; Cao Q; Luo R; Hu W; Lyu S; Zhang Z; Xie D; Ye Y; Wang Y; Cai M
    Nat Commun; 2024 May; 15(1):3768. PubMed ID: 38704409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic impact of preoperative corticosteroids in primary central nervous system lymphoma.
    Bullis CL; Maldonado-Perez A; Bowden SG; Yaghi N; Munger D; Wood MD; Barajas RF; Ambady P; Neuwelt EA; Han SJ
    J Clin Neurosci; 2020 Feb; 72():287-291. PubMed ID: 31648968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary central nervous system lymphoma: Imaging features and differential diagnosis.
    Ribas GA; de Mori LH; Freddi TAL; Oliveira LDS; de Souza SR; Corrêa DG
    Neuroradiol J; 2024 May; ():19714009241252625. PubMed ID: 38703015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resection or Biopsy: The Efficacy of Different Surgical Approaches for Primary Central Nervous System Lymphoma.
    Zhang Y; Wang Z; Wang D; Yu B; Wen J; He S; Zeng W; Wang C
    Turk Neurosurg; 2024; 34(3):401-406. PubMed ID: 38650554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microscopic biopsy after unsuccessful endoscopic biopsy for primary central nervous system lymphoma of the corpus callosum: A case report.
    Kanazawa T; Karatsu K; Kuramae T; Ishihara M
    Ann Med Surg (Lond); 2021 Sep; 69():102746. PubMed ID: 34471530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Could Cerebral Inflammatory Lesions be the Cellular Origin of Primary Central Nervous System Lymphoma?
    Ma J; Wang H; Chen T; Bai H; Zhang J; Yu X
    J Craniofac Surg; 2024 May; ():. PubMed ID: 38709059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Analysis of Liquid Vitreous Biopsy Reveals Occult Lymphoma Following Cytology-Negative Biopsies of the Brain and Vitreous.
    Balikov DA; Conway K; Brown NA; Camelo-Piragua S; Rao RC
    Ocul Immunol Inflamm; 2023 Dec; ():1-9. PubMed ID: 38109211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter to editor: C‑reactive protein levels, the prognostic nutritional index, and the lactate dehydrogenase‑to‑lymphocyte ratio are important prognostic factors in primary central nervous system lymphoma: a single‑center study of 223 patients.
    Un Nisa Mughal Z; Haseeb A
    Neurosurg Rev; 2024 Apr; 47(1):146. PubMed ID: 38600419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid.
    Douville C; Curtis S; Summers M; Azad TD; Rincon-Torroella J; Wang Y; Mattox A; Avigdor B; Dudley J; Materi J; Raj D; Nair S; Bhanja D; Tuohy K; Dobbyn L; Popoli M; Ptak J; Nehme N; Silliman N; Blair C; Judge K; Gallia GL; Groves M; Jackson CM; Jackson EM; Laterra J; Lim M; Mukherjee D; Weingart J; Naidoo J; Koschmann C; Smith N; Schreck KC; Pardo CA; Glantz M; Holdhoff M; Kinzler KW; Papadopoulos N; Vogelstein B; Bettegowda C
    Cell Rep Med; 2023 Aug; 4(8):101148. PubMed ID: 37552989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Central Nervous System Lymphoma Presenting As Chronic Subdural Hematoma: Case Report and Review of the Literature.
    Semonche A; Gomez P; Kolcun JPG; Perez-Roman RJ; Starke RM
    Cureus; 2020 Feb; 12(2):e7043. PubMed ID: 32211275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical profile of central nervous system space-occupying lesions and their association with CD4 counts in patients with HIV: A prospective observational study.
    Sawardekar VM; Sawadh RK; Sawardekar V; Singh B; Wankhade B
    J Family Med Prim Care; 2024 Mar; 13(3):952-957. PubMed ID: 38736804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Presentation of Primary CNS Lymphoma Mimicking Toxoplasma in HIV Infection.
    Acharya I; DeBoer SR; Bhansali D
    J Community Hosp Intern Med Perspect; 2023; 13(6):17-23. PubMed ID: 38596565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: a RANO review.
    Nayak L; Bettegowda C; Scherer F; Galldiks N; Ahluwalia M; Baraniskin A; von Baumgarten L; Bromberg JEC; Ferreri AJM; Grommes C; Hoang-Xuan K; Kühn J; Rubenstein JL; Rudà R; Weller M; Chang SM; van den Bent MJ; Wen PY; Soffietti R
    Neuro Oncol; 2024 Apr; ():. PubMed ID: 38598668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathological Diagnosis of Primary Central Nervous System Lymphoma after Therapy with Corticosteroids or Anticoagulants.
    Feldheim J; Darkwah Oppong M; Feldheim JA; Jabbarli R; Dammann P; Uerschels AK; Gembruch O; Ahmadipour Y; Deuschl C; Junker A; Sure U; Wrede KH
    Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early postoperative outcomes in lumpectomy versus simple mastectomy.
    Chatterjee A; Pyfer B; Czerniecki B; Rosenkranz K; Tchou J; Fisher C
    J Surg Res; 2015 Sep; 198(1):143-8. PubMed ID: 26070497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant Chemotherapy Followed by Maintenance Therapy With or Without Bevacizumab in Unresectable High-Grade Serous Ovarian Cancer: A Case-Control Study.
    Petrillo M; Paris I; Vizzielli G; Amadio G; Cosentino F; Salutari V; Scambia G; Fagotti A
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S952-8. PubMed ID: 26036187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.